Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CDFH009273
| Cat. No. | CDFH009273 |
| Product Type | cDNA clone |
| Gene Abbr | INPP5A |
| Gene Name | INPP5A inositol polyphosphate-5-phosphatase, 40kDa [ Homo sapiens ] |
| Species | Human |
| Size | 10 ug |
| Vector | pCMV6-XL |
| Gene Name | INPP5A inositol polyphosphate-5-phosphatase, 40kDa [ Homo sapiens ] |
| Gene Symbol | INPP5A |
| Synonyms | INPP5A; inositol polyphosphate-5-phosphatase, 40kDa; inositol polyphosphate 5 phosphatase, 40kD; type I inositol 1,4,5-trisphosphate 5-phosphatase; 5PTASE; 43 kDa inositol polyphosphate 5 phophatase; CTCL tumor antigen HD CL 02; inositol polyphosphate 5 phophatase; 40kDa; InsP3 5 phosphatase; type I inositol 1; 4; 5 trisphosphate 5 phosphatase; InsP3 5-phosphatase; CTCL tumor antigen HD-CL-02; 43 kDa inositol polyphosphate 5-phophatase; inositol trisphosphate-5-phosphatase, 40kD; type I inositol-1,4,5-trisphosphate 5-phophatase; type I inositol-1,4,5-trisphosphate 5-phosphatase; MGC116947; MGC116949; DKFZp434A1721; |
| Gene ID | 3632 |
| Uni Prot ID | Q14642 |
| m RNA Refseq | BC096280 |
| Chromosome Location | 10q26.3 |
| Pathway | 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian), organism-specific biosystem; 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian), conserved biosystem; D-myo-inositol -trisphosphate biosynthesis, organism-specific biosystem; D-myo-inositol -trisphosphate biosynthesis, conserved biosystem; D-myo-inositol -trisphosphate degradation, organism-specific biosystem; D-myo-inositol -trisphosphate degradation, conse |
| MIM | 600106 |
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.